Angelina Jolie and Brad Pitt just can’t get enough - of AIDS advocacy. With Brad’s soon-to-be ex Jennifer Aniston jilted publicly and Brad and Angelina slandered and stalked, the only bliss from their “alleged” affair may be the tabloids’. But AIDS awareness has also copped a boon.
One-a-Day Med Too Good To Be True? When HIVers heard the word this week that the first-ever one-pill-once-a-day regimen from Gilead Sciences and Bristol-Myers Squibb wasn’t developing according to plan, there wasn’t exactly panic in the streets. But longtime survivors may have wondered if the prospect of a one-a-day—which made the early years of combo therapy’s routine fistful of pills three times daily seem like ancient history—was just one more dashed treatment dream. Was there more to Gilead’s official explanation than met the eye? Had the partnership between competitors Gilead and BMS—unprecedented in the high-stakes, cut-throat HIV drug industry—hit the rocks?
Leading Advocate Resigns from AIDS Action Council A long-serving board member of AIDS Action Council, the nation’s leading lobby for people with HIV, resigned this week from the Foundation Board in protest of what he termed the group’s “timidity” in its collaboration with the Bush administration, whose policies he called “evil.” Craig Miller’s impassioned and embittered letter of resignation, dated April 25 and leaked to POZ, deplored the 20-year-old AAC’s growing lack of “responsiveness” to the 3,200 AIDS service organizations that it is “entrusted to represent.”
